• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

3.070 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook ↗
March 10, 2026
Via Chartmill
News headline image
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
March 10, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conferences
March 03, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
February 24, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Announces Select Preliminary 2025 Financial Results
January 11, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
 
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Exagen Stock ↗
September 11, 2025
 
Via Benzinga
News headline image
What Analysts Are Saying About Exagen Stock ↗
July 30, 2025
 
Via Benzinga
News headline image
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 11, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss ↗
November 04, 2025
Exagen's Q3 2025 results show a revenue beat but a wider-than-expected loss, causing a pre-market stock decline. 
Via Chartmill
News headline image
Exagen Inc. Reports Strong Q3 2025 Results
November 04, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗
October 27, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For July 29, 2025 ↗
July 29, 2025
 
Via Benzinga
News headline image
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
October 23, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Demystifying Exagen: Insights From 5 Analyst Reviews ↗
October 22, 2025
 
Via Benzinga
News headline image
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
October 21, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Third Quarter Investor Conferences
August 06, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
July 29, 2025
 
Via Benzinga
News headline image
Exagen Q2 Revenue Jumps 14 Percent ↗
July 29, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Exagen Inc (NASDAQ:XGN) Surpasses Revenue Estimates in Q2 2025 Despite Wider Loss, Shares Rally in Pre-Market Trading ↗
July 29, 2025
Exagen Inc (XGN) beats Q2 2025 revenue estimates with $17.2M but posts wider loss. Stock jumps 6.77% pre-market as investors focus on growth potential. 
Via Chartmill
News headline image
Exagen Inc. Reports Strong Q2 2025 Results
July 29, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Appoints Chas McKhann to Board of Directors
July 17, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
July 15, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
June 23, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
May 09, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
Top movers in Thursday's pre-market session ↗
May 08, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Exagen Inc. Prices Public Offering of Common Stock
May 08, 2025
From Exagen Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
May 08, 2025
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
May 07, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 07, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap